KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Current Assets (2017 - 2025)

Historic Current Assets for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $20.2 billion.

  • Takeda Pharmaceutical's Current Assets rose 1175.62% to $20.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.2 billion, marking a year-over-year increase of 1175.62%. This contributed to the annual value of $16.6 billion for FY2025, which is 670.89% down from last year.
  • As of Q4 2025, Takeda Pharmaceutical's Current Assets stood at $20.2 billion, which was up 1175.62% from $19.8 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's Current Assets' 5-year high stood at $25.6 billion during Q1 2021, with a 5-year trough of $16.4 billion in Q4 2023.
  • For the 5-year period, Takeda Pharmaceutical's Current Assets averaged around $19.6 billion, with its median value being $19.8 billion (2022).
  • In the last 5 years, Takeda Pharmaceutical's Current Assets plummeted by 1877.17% in 2023 and then skyrocketed by 2009.65% in 2024.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Current Assets stood at $21.8 billion in 2021, then dropped by 15.71% to $18.4 billion in 2022, then fell by 10.58% to $16.4 billion in 2023, then rose by 10.26% to $18.1 billion in 2024, then grew by 11.76% to $20.2 billion in 2025.
  • Its Current Assets stands at $20.2 billion for Q4 2025, versus $19.8 billion for Q3 2025 and $17.4 billion for Q2 2025.